Immuneering Corp - FORM S-1 - EX-23.1 - EXHIBIT 23.1 - July 9, 2021

Attached files

file filename
EX-3.2 - EXHIBIT 3.2 - Immuneering Corptm2115679d7_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - Immuneering Corptm2115679d7_ex3-1.htm
EX-10.2 - EXHIBIT 10.2 - Immuneering Corptm2115679d7_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Immuneering Corptm2115679d7_ex10-1.htm
EX-10.5 - EXHIBIT 10.5 - Immuneering Corptm2115679d7_ex10-5.htm
EX-10.3 - EXHIBIT 10.3 - Immuneering Corptm2115679d7_ex10-3.htm
EX-10.4 - EXHIBIT 10.4 - Immuneering Corptm2115679d7_ex10-4.htm
S-1 - S-1 - Immuneering Corptm2115679-6_s1.htm

 

Exhibit 23.1 

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the use in this Registration Statement on Form S-1 of Immuneering Corporation of our report dated May 13, 2021, relating to the consolidated financial statements of Immuneering Corporation Inc. and its subsidiary, appearing in the Prospectus, which is part of this Registration Statement.

 

We also consent to the reference to our firm under the heading "Experts" in such Prospectus.

 

/s/ RSM US LLP  
   
Boston, Massachusetts  
July 9, 2021